4.4 Review

Newborn screening for the full set of mucopolysaccharidoses in dried blood spots based on first-tier enzymatic assay followed by second-tier analysis of glycosaminoglycans

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Endogenous, non-reducing end glycosaminoglycan biomarkers are superior to internal disaccharide glycosaminoglycan biomarkers for newborn screening of mucopolysaccharidoses and GM1 gangliosidosis

Zackary M. Herbst et al.

Summary: This study evaluated two methods for measuring GAG biomarkers in different types of MPS and GM1 gangliosidosis. The use of the endogenous NRE biomarker method for second-tier GAG analysis was found to be effective in reducing the false positive rate in NBS.

MOLECULAR GENETICS AND METABOLISM (2023)

Article Pediatrics

First Three Years' Experience of Mucopolysaccharidosis Type-I Newborn Screening in California

Toki Fillman et al.

Summary: This study reports on the first 3 years of mucopolysaccharidosis type I (MPS I) newborn screening in California. A 2-tiered approach was used, with enzyme activity assay and DNA sequencing. 7 cases of Hurler syndrome and 2 cases of attenuated MPS I were identified among the screened newborns. Continued long-term follow-up is crucial for understanding the genotype-phenotype relationships of MPS I.

JOURNAL OF PEDIATRICS (2023)

Article Genetics & Heredity

Novel subtype of mucopolysaccharidosis caused by arylsulfatase K (ARSK) deficiency

Sarah Verheyen et al.

Summary: This study reports four affected individuals from two unrelated consanguineous families with MPS-related features, showing additional cardiac and ophthalmological abnormalities in some cases. The detection of mild elevation of a specific GAG in some subjects suggests a novel subtype of mucopolysaccharidosis, which is proposed to be named subtype X.

JOURNAL OF MEDICAL GENETICS (2022)

Article Genetics & Heredity

Evaluation of Two Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis Type II

Zackary M. Herbst et al.

Summary: This study supports the use of second-tier GAG analysis of newborn DBS, especially the endogenous disaccharide method, as part of NBS to reduce the false positive rate.

INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2022)

Article Neurosciences

The future of newborn screening for lysosomal disorders

Melissa P. Wasserstein et al.

Summary: The goal of newborn screening is to detect serious and treatable disorders early to improve patient outcomes. Lysosomal storage disorders (LSDs), a group of over 50 diseases, are being increasingly screened in newborns with the aim of reducing disease morbidity and mortality through early detection using a variety of methods including enzyme replacement therapies and gene therapies.

NEUROSCIENCE LETTERS (2021)

Article Genetics & Heredity

Validation and Implementation of a Highly Sensitive and Efficient Newborn Screening Assay for Mucopolysaccharidosis Type II

Heather Bilyeu et al.

INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2020)

Article Endocrinology & Metabolism

Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry

Francyne Kubaski et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2017)

Article Endocrinology & Metabolism

Glycosaminoglycans detection methods: Applications of mass spectrometry

Francyne Kubaski et al.

MOLECULAR GENETICS AND METABOLISM (2017)

Article Medical Laboratory Technology

An improved method for glycosaminoglycan analysis by LC-MS/MS of urine samples collected on filter paper

Christiane Auray-Blais et al.

CLINICA CHIMICA ACTA (2012)

Article Biochemistry & Molecular Biology

Disease-specific non-reducing end carbohydrate biomarkers for mucopolysaccharidoses

Roger Lawrence et al.

NATURE CHEMICAL BIOLOGY (2012)

Article Endocrinology & Metabolism

Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses

S Tomatsu et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2005)